- Home
- VOR vs CRMD Comparison
VOR vs CRMD Comparison
Compare VOR & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VOR | CRMD |
|---|---|---|
| Founded | 2015 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 813.3M | 695.9M |
| IPO Year | 2021 | 2009 |
Fundamental Metrics
Financial Performance| Metric | VOR | CRMD |
|---|---|---|
| Price | $19.14 | $8.38 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 10 | 6 |
| Target Price | ★ $45.33 | $14.83 |
| AVG Volume (30 Days) | ★ 1.8M | 1.4M |
| Earning Date | 05-11-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 780.00 |
| EPS | N/A | ★ 0.43 |
| Revenue | N/A | ★ $311,709,000.00 |
| Revenue This Year | N/A | $0.30 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $20.16 |
| Revenue Growth | N/A | ★ 617.03 |
| 52 Week Low | $1.62 | $6.13 |
| 52 Week High | $49.95 | $14.96 |
Technical Indicators
Market Signals| Indicator | VOR | CRMD |
|---|---|---|
| Relative Strength Index (RSI) | 64.07 | 49.14 |
| Support Level | $11.62 | $8.09 |
| Resistance Level | $19.70 | $8.90 |
| Average True Range (ATR) | 1.56 | 0.41 |
| MACD | 0.34 | 0.01 |
| Stochastic Oscillator | 62.75 | 55.75 |
Price Performance
Historical ComparisonAbout VOR Vor Biopharma Inc.
Vor Biopharma Inc is a clinical-stage biopharmaceutical company focused on developing novel therapies for the treatment of autoimmune diseases. Its program, telitacicept, is a potential first- and best-in-class dual BAFF/APRIL inhibitor designed to suppress the signaling pathways that drive the maturation, proliferation, and survival of harmful B cells, including self-reactive B cells, thereby reducing autoantibody production and preventing downstream tissue damage.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions. The Company's focus is on the commercialization of its product, DefenCath, in the United States and other key markets. The group currently operates in a single segment, Drug Product, located in a single geographic location, the United States.